Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies

BACKGROUND: Liver cirrhosis is one of the end-stage chronic liver diseases. Individuals with chronic hepatitis B (CHB) are at an increased risk of developing liver cirrhosis. Practice guidelines underline that Nucleos(t)ide analogs (NAs) should be the first-line treatment for hepatitis B virus (HBV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chaoyuan, Shen, Danting, Sun, Shuning, Huang, Yuancheng, Xin, Yijun, Luo, Hu, Chen, Yinzhen, Zhou, Zipu, Liu, Fengbin, Chen, Xinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831400/
https://www.ncbi.nlm.nih.gov/pubmed/31027094
http://dx.doi.org/10.1097/MD.0000000000015297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831400/
https://www.ncbi.nlm.nih.gov/pubmed/31027094
http://dx.doi.org/10.1097/MD.0000000000015297

Ejemplares similares